• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与幽门螺杆菌耐药相关的胃微生物组变化。

Gastric microbiome changes in relation with Helicobacter pylori resistance.

机构信息

Oita University Faculty of Medicine, Department of Infectious Disease Control, Yufu, Oita, Japan.

Faculty of Medicine, Department of Anatomy, Histology and Pharmacology, Universitas Airlangga, Surabaya, Indonesia.

出版信息

PLoS One. 2023 May 18;18(5):e0284958. doi: 10.1371/journal.pone.0284958. eCollection 2023.

DOI:10.1371/journal.pone.0284958
PMID:37200323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10194900/
Abstract

INTRODUCTION

Inadequate antimicrobial treatment has led to multidrug-resistant (MDR) bacteria, including Helicobacter pylori (H. pylori), which one of the notable pathogens in the stomach. Antibiotic-induced changes in the microbiota can negatively affect the host. This study aimed to determine the influence of H. pylori resistance on the diversity and abundance of the stomach microbiome.

METHODS

Bacterial DNA was extracted from biopsy samples of patients presenting dyspepsia symptoms with H. pylori positive from cultures and histology. DNA was amplified from the V3-V4 regions of the 16S rRNA gene. In-vitro E-test was used to detect antibiotic resistance. Microbiome community analysis was conducted through α-diversity, β-diversity, and relative abundance.

RESULTS

Sixty-nine H. pylori positive samples were eligible after quality filtering. Following resistance status to five antibiotics, samples were classified into 24 sensitive, 24 single resistance, 16 double resistance, 5 triple resistance. Samples were mostly resistant to metronidazole (73.33%; 33/45). Comparation of four groups displayed significantly elevated α-diversity parameters under the multidrug resistance condition (all P <0.05). A notable change was observed in triple-resistant compared to sensitive (P <0.05) and double-resistant (P <0.05) groups. Differences in β-diversity by UniFrac and Jaccard were not significant in terms of the resistance (P = 0.113 and P = 0.275, respectively). In the triple-resistant group, the relative abundance of Helicobacter genera was lower, whereas that of Streptococcus increased. Moreover, the linear discriminant analysis effect size (LEfSe) was associated with the presence of Corynebacterium and Saccharimonadales in the single-resistant group and Pseudomonas and Cloacibacterium in the triple-resistant group.

CONCLUSION

Our results suggest that the resistant samples showed a higher trend of diversity and evenness than the sensitive samples. The abundance of H. pylori in the triple-resistant samples decreased with increasing cohabitation of pathogenic bacteria, which may support antimicrobial resistance. However, antibiotic susceptibility determined by the E-test may not completely represent the resistance status.

摘要

简介

抗菌治疗不充分导致了包括幽门螺杆菌(H. pylori)在内的多种耐药菌的出现,H. pylori 是胃中一种重要的病原体。抗生素诱导的微生物群变化可能会对宿主产生负面影响。本研究旨在确定 H. pylori 耐药性对胃微生物组多样性和丰度的影响。

方法

从培养和组织学中呈 H. pylori 阳性的消化不良症状患者的活检样本中提取细菌 DNA。从 16S rRNA 基因的 V3-V4 区扩增 DNA。使用体外 E 试验检测抗生素耐药性。通过 α 多样性、β 多样性和相对丰度进行微生物组群落分析。

结果

经过质量过滤后,共有 69 个 H. pylori 阳性样本符合条件。根据对五种抗生素的耐药情况,将样本分为 24 个敏感组、24 个单耐药组、16 个双耐药组和 5 个三耐药组。样本对甲硝唑的耐药率最高(73.33%;33/45)。在多药耐药条件下,四个组的 α 多样性参数显著升高(均 P <0.05)。与敏感组(P <0.05)和双耐药组(P <0.05)相比,三耐药组的变化更为显著。基于 UniFrac 和 Jaccard 的 β 多样性差异在耐药性方面没有统计学意义(分别为 P = 0.113 和 P = 0.275)。在三耐药组中,Helicobacter 属的相对丰度较低,而链球菌属的相对丰度增加。此外,线性判别分析效应量(LEfSe)与单耐药组中 Corynebacterium 和 Saccharimonadales 的存在以及三耐药组中 Pseudomonas 和 Cloacibacterium 的存在相关。

结论

我们的结果表明,耐药样本的多样性和均匀度呈上升趋势,高于敏感样本。三耐药样本中 H. pylori 的丰度随着共生致病菌的增加而降低,这可能支持抗生素耐药性。然而,E 试验确定的抗生素药敏性可能并不能完全代表耐药状态。

相似文献

1
Gastric microbiome changes in relation with Helicobacter pylori resistance.与幽门螺杆菌耐药相关的胃微生物组变化。
PLoS One. 2023 May 18;18(5):e0284958. doi: 10.1371/journal.pone.0284958. eCollection 2023.
2
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.幽门螺杆菌根除后肠道微生物群、抗生素耐药性和代谢参数的长期变化:一项多中心、开放标签、随机试验。
Lancet Infect Dis. 2019 Oct;19(10):1109-1120. doi: 10.1016/S1473-3099(19)30272-5.
3
Shotgun Metagenomics of Gastric Biopsies Reveals Compositional and Functional Microbiome Shifts in High- and Low-Gastric-Cancer-Risk Populations from Colombia, South America.经哥伦比亚(南美洲)高、低胃癌风险人群胃活检组织的 shotgun 宏基因组学分析揭示其微生物群落组成和功能的变化
Gut Microbes. 2023 Jan-Dec;15(1):2186677. doi: 10.1080/19490976.2023.2186677.
4
Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.质子泵抑制剂对消化不良患者胃黏膜相关微生物群的影响。
Appl Environ Microbiol. 2016 Oct 27;82(22):6633-6644. doi: 10.1128/AEM.01437-16. Print 2016 Nov 15.
5
Characterization of the Gastric Microbiota in a Pediatric Population According to Helicobacter pylori Status.根据幽门螺杆菌感染状况对儿科人群胃微生物群的特征分析
Pediatr Infect Dis J. 2017 Feb;36(2):173-178. doi: 10.1097/INF.0000000000001383.
6
Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing.采用 16S rRNA 基因测序技术评估肠上皮化生患者的胃微生物组和宏基因组功能。
Helicobacter. 2019 Feb;24(1):e12547. doi: 10.1111/hel.12547. Epub 2018 Nov 15.
7
Evaluation of the Gastric Microbiome in Patients with Chronic Superficial Gastritis and Intestinal Metaplasia.慢性浅表性胃炎和肠化生患者胃微生物群的评估
Chin Med Sci J. 2022 Mar 31;37(1):44-51. doi: 10.24920/003889.
8
Characterization of gut microbiome and metabolome in patients in an underprivileged community in the United States.美国贫困社区患者的肠道微生物组和代谢组学特征。
World J Gastroenterol. 2021 Sep 7;27(33):5575-5594. doi: 10.3748/wjg.v27.i33.5575.
9
Gastric Microbiota in a Low-Helicobacter pylori Prevalence General Population and Their Associations With Gastric Lesions.低幽门螺杆菌流行人群的胃微生物群及其与胃病变的关系。
Clin Transl Gastroenterol. 2020 Jul;11(7):e00191. doi: 10.14309/ctg.0000000000000191.
10
Effects of Helicobacter pylori and Helicobacter pylori eradication on the microbiota of tongue coating.舌涂层中幽门螺杆菌和幽门螺杆菌根除对微生物群的影响。
BMC Microbiol. 2024 Oct 18;24(1):416. doi: 10.1186/s12866-024-03584-y.

引用本文的文献

1
The impact of infection and eradication therapies on gut microbiota: a systematic review of microbial dysbiosis and its implications in gastric carcinogenesis.感染与根除疗法对肠道微生物群的影响:微生物失调及其在胃癌发生中的意义的系统评价
Front Cell Infect Microbiol. 2025 Jul 7;15:1592977. doi: 10.3389/fcimb.2025.1592977. eCollection 2025.
2
causes gastric dysbacteriosis in chronic gastritis patients.导致慢性胃炎患者胃内菌群失调。
Open Life Sci. 2024 Mar 28;19(1):20220839. doi: 10.1515/biol-2022-0839. eCollection 2024.
3
Helicobacter pylori and oral-gut microbiome: clinical implications.

本文引用的文献

1
Gene sharing among plasmids and chromosomes reveals barriers for antibiotic resistance gene transfer.质粒和染色体之间的基因共享揭示了抗生素抗性基因转移的障碍。
Philos Trans R Soc Lond B Biol Sci. 2022 Jan 17;377(1842):20200467. doi: 10.1098/rstb.2020.0467. Epub 2021 Nov 29.
2
Role of and Other Environmental Factors in the Development of Gastric Dysbiosis.幽门螺杆菌及其他环境因素在胃微生物群失调发展中的作用
Pathogens. 2021 Sep 16;10(9):1203. doi: 10.3390/pathogens10091203.
3
Resistome and microbial profiling of pediatric patient's gut infected with multidrug-resistant diarrhoeagenic using next-generation sequencing; the first study from Pakistan.
幽门螺杆菌与口-肠道微生物群:临床意义。
Infection. 2024 Apr;52(2):289-300. doi: 10.1007/s15010-023-02115-7. Epub 2023 Nov 2.
采用下一代测序技术对感染多重耐药性腹泻病原菌的儿科患者肠道的耐药组和微生物组进行分析;来自巴基斯坦的第一项研究。
Libyan J Med. 2021 Dec;16(1):1915615. doi: 10.1080/19932820.2021.1915615.
4
Role of the Gastric Microbiome in Gastric Cancer: From Carcinogenesis to Treatment.胃微生物群在胃癌中的作用:从致癌作用到治疗
Front Microbiol. 2021 Mar 15;12:641322. doi: 10.3389/fmicb.2021.641322. eCollection 2021.
5
Alterations of Gastric Microbiota in Gastric Cancer and Precancerous Stages.胃癌及癌前病变阶段胃微生物群的改变。
Front Cell Infect Microbiol. 2021 Mar 3;11:559148. doi: 10.3389/fcimb.2021.559148. eCollection 2021.
6
Helicobacter pylori Antimicrobial Resistance and Gene Variants in High- and Low-Gastric-Cancer-Risk Populations.高、低胃癌风险人群中幽门螺杆菌的抗菌药物耐药性和基因变异。
J Clin Microbiol. 2021 Apr 20;59(5). doi: 10.1128/JCM.03203-20.
7
Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review.英国初级医疗中最常用抗生素对人体肠道微生物群的影响:一项系统评价
BMJ Open. 2020 Sep 21;10(9):e035677. doi: 10.1136/bmjopen-2019-035677.
8
Biofilm Formation and Antibiotic Resistance Phenotype of Clinical Isolates.临床分离株的生物膜形成与抗生素耐药表型。
Toxins (Basel). 2020 Jul 24;12(8):473. doi: 10.3390/toxins12080473.
9
Gastric microbiota and Helicobacter pylori in Indonesian population.印度尼西亚人群的胃微生物群和幽门螺杆菌。
Helicobacter. 2020 Aug;25(4):e12695. doi: 10.1111/hel.12695. Epub 2020 May 12.
10
Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: A Narrative Review.肠道微生物群、抗生素治疗与抗菌药物耐药性:一项叙述性综述
Microorganisms. 2020 Feb 17;8(2):269. doi: 10.3390/microorganisms8020269.